• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未使用过抗精神病药物的精神分裂症患者的胰岛素及胰岛素样生长因子-1异常

Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.

作者信息

Venkatasubramanian Ganesan, Chittiprol Seetharamaiah, Neelakantachar Narendran, Naveen Magadi N, Thirthall Jagadisha, Gangadhar Bangalore N, Shetty K Taranath

机构信息

Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore 560029, Karnataka, India.

出版信息

Am J Psychiatry. 2007 Oct;164(10):1557-60. doi: 10.1176/appi.ajp.2007.07020233.

DOI:10.1176/appi.ajp.2007.07020233
PMID:17898347
Abstract

OBJECTIVE

The purpose of this study was to examine the evidence for the insulin-like growth factor-1 (IGF-1) deficiency hypothesis in the pathogenesis of schizophrenia.

METHOD

The authors examined the fasting plasma levels of glucose, insulin, IGF-1, and cortisol in antipsychotic-naive schizophrenia patients (N=44) relative to age- and sex-matched healthy comparison subjects (N=44). Patients and comparison subjects were also matched for anthropometric measures and physical activity.

RESULTS

Schizophrenia patients had a significantly higher mean plasma insulin level as well as a significantly higher mean insulin resistance score relative to healthy comparison subjects. The mean plasma IGF-1 level was significantly lower in patients. IGF-1 levels had a significant negative correlation with plasma insulin levels. The total positive symptoms score as well as the hallucinations subscore had a significant inverse relationship with IGF-1 levels.

CONCLUSIONS

Deficient IGF-1 might underlie insulin resistance in schizophrenia. The IGF-1 deficit in antipsychotic-naive schizophrenia patients and its significant correlation with psychopathology scores suggest that IGF-1 might be potentially involved in the pathogenesis of schizophrenia.

摘要

目的

本研究旨在检验胰岛素样生长因子-1(IGF-1)缺乏假说在精神分裂症发病机制中的证据。

方法

作者检测了未服用抗精神病药物的精神分裂症患者(N = 44)相对于年龄和性别匹配的健康对照受试者(N = 44)的空腹血浆葡萄糖、胰岛素、IGF-1和皮质醇水平。患者和对照受试者在人体测量指标和身体活动方面也进行了匹配。

结果

与健康对照受试者相比,精神分裂症患者的平均血浆胰岛素水平显著更高,平均胰岛素抵抗评分也显著更高。患者的平均血浆IGF-1水平显著更低。IGF-1水平与血浆胰岛素水平呈显著负相关。总的阳性症状评分以及幻觉子评分与IGF-1水平呈显著负相关。

结论

IGF-1缺乏可能是精神分裂症患者胰岛素抵抗的基础。未服用抗精神病药物的精神分裂症患者的IGF-1缺乏及其与精神病理学评分的显著相关性表明,IGF-1可能潜在参与了精神分裂症的发病机制。

相似文献

1
Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.未使用过抗精神病药物的精神分裂症患者的胰岛素及胰岛素样生长因子-1异常
Am J Psychiatry. 2007 Oct;164(10):1557-60. doi: 10.1176/appi.ajp.2007.07020233.
2
Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.抗精神病药物治疗对精神分裂症患者胰岛素样生长因子-1 和皮质醇的影响:一项纵向研究。
Schizophr Res. 2010 Jun;119(1-3):131-7. doi: 10.1016/j.schres.2010.01.033. Epub 2010 Mar 11.
3
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.首发、未用药的精神分裂症患者空腹血糖耐量受损。
Am J Psychiatry. 2003 Feb;160(2):284-9. doi: 10.1176/appi.ajp.160.2.284.
4
Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients.首发精神分裂症和双相情感障碍患者阴性症状与胰岛素样生长因子 1 血浆水平的关系。
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:29-33. doi: 10.1016/j.pnpbp.2013.01.008. Epub 2013 Jan 18.
5
Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia.在患有精神分裂症的急性病非糖尿病住院患者中,较高的空腹血清胰岛素水平与较好的精神病理学特征相关。
Schizophr Res. 2006 Sep;86(1-3):30-5. doi: 10.1016/j.schres.2006.04.010. Epub 2006 Jun 5.
6
Abnormality of glycometabolism related factors in non-psychotic offspring of schizophrenic patients.精神分裂症患者非精神病性后代糖代谢相关因素的异常。
Psychiatry Res. 2012 Jul 30;198(2):183-6. doi: 10.1016/j.psychres.2011.12.014. Epub 2012 Mar 9.
7
Glucose disturbances in first-episode drug-naïve schizophrenia: Relationship to psychopathology.首发未用药精神分裂症患者的葡萄糖代谢紊乱:与精神病理学的关系
Psychoneuroendocrinology. 2015 Dec;62:376-80. doi: 10.1016/j.psyneuen.2015.09.005. Epub 2015 Sep 8.
8
Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.氯氮平治疗的精神分裂症肥胖症与非精神性肥胖症中的葡萄糖-胰岛素稳态、血脂谱及生长激素-胰岛素样生长因子-胰岛素样生长因子结合蛋白轴
Int J Obes (Lond). 2008 Mar;32(3):436-42. doi: 10.1038/sj.ijo.0803750. Epub 2007 Oct 23.
9
Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome.IGF-1、精神分裂症与代谢综合征治疗之间的关系。
Compr Psychiatry. 2014 Aug;55(6):1391-7. doi: 10.1016/j.comppsych.2014.04.008. Epub 2014 Apr 12.
10
Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy.接受氯氮平单一疗法的精神分裂症患者的血糖、胰岛素血液水平及胰岛素抵抗情况。
Diabetes Metab Syndr. 2014 Oct-Dec;8(4):236-41. doi: 10.1016/j.dsx.2014.09.020. Epub 2014 Oct 11.

引用本文的文献

1
The Insulin-like Growth Factor Family as a Potential Peripheral Biomarker in Psychiatric Disorders: A Systematic Review.胰岛素样生长因子家族作为精神疾病潜在的外周生物标志物:一项系统综述
Int J Mol Sci. 2025 Mar 12;26(6):2561. doi: 10.3390/ijms26062561.
2
Molecular overlaps of neurological manifestations of COVID-19 and schizophrenia from a proteomic perspective.从蛋白质组学角度看新冠病毒病与精神分裂症神经学表现的分子重叠
Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):109-122. doi: 10.1007/s00406-024-01842-8. Epub 2024 Jul 19.
3
Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder.
蛋白质在血液中的浓度 胰岛素样生长因子信号系统在重度抑郁症中改变。
Int J Mol Sci. 2023 Oct 17;24(20):15254. doi: 10.3390/ijms242015254.
4
The neurobiology of insulin-like growth factor I: From neuroprotection to modulation of brain states.胰岛素样生长因子I的神经生物学:从神经保护到脑状态调节。
Mol Psychiatry. 2023 Aug;28(8):3220-3230. doi: 10.1038/s41380-023-02136-6. Epub 2023 Jun 23.
5
Mechanism and treatments of antipsychotic-induced weight gain.抗精神病药引起的体重增加的机制和治疗方法。
Int J Obes (Lond). 2023 Jun;47(6):423-433. doi: 10.1038/s41366-023-01291-8. Epub 2023 Mar 23.
6
Meta-analysis of peripheral insulin-like growth factor 1 levels in schizophrenia.精神分裂症外周胰岛素样生长因子 1 水平的荟萃分析。
Brain Behav. 2023 Jan;13(1):e2819. doi: 10.1002/brb3.2819. Epub 2022 Nov 30.
7
Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients.胰岛素样生长因子 2 (IGF-2) 和胰岛素样生长因子结合蛋白 7 (IGFBP-7) 在西班牙精神分裂症患者使用非典型抗精神病药物后上调。
Int J Mol Sci. 2022 Aug 24;23(17):9591. doi: 10.3390/ijms23179591.
8
Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases.脑葡萄糖代谢低下、胰岛素信号转导改变和胰岛素抵抗在几种神经疾病中的意义。
Front Endocrinol (Lausanne). 2022 May 9;13:873301. doi: 10.3389/fendo.2022.873301. eCollection 2022.
9
Translational relevance of forward genetic screens in animal models for the study of psychiatric disease.动物模型中正向遗传学筛选在精神疾病研究中的转化相关性。
Neurosci Biobehav Rev. 2022 Apr;135:104559. doi: 10.1016/j.neubiorev.2022.104559. Epub 2022 Feb 4.
10
Oxytocin-pathway polygenic scores for severe mental disorders and metabolic phenotypes in the UK Biobank.英国生物库中严重精神障碍和代谢表型的催产素途径多基因评分。
Transl Psychiatry. 2021 Nov 25;11(1):599. doi: 10.1038/s41398-021-01725-9.